Tissue engineering typically uses a combination of biomaterial scaffolds, cells and signaling mechanisms (such as growth factors or mechanical stimuli) to restore the function of damaged or degenerated tissues. The research carried out in our laboratory investigates each of these three areas with target applications in tissues including bone, cartilage, skin, cardiovascular, respiratory, and neural tissues. 3D printing has allowed us to tune the mechanical properties of our scaffolds and to develop bioinks with enhanced regenerative potential.Continue reading “3D printing of scaffolds and biomolecules for enhanced tissue repair”
Organs are complex systems, comprised of different tissues, proteins, and cells, which communicate to orchestrate a myriad of functions in our bodies. Technologies are needed to replicate these structures towards the development of new therapies for tissue and organ repair, as well as for in vitro 3D models to better understand the morphogenetic biological processes that drive organogenesis.Continue reading “From Scaffold Design to Control Stem Cell Fate to Bioprinting”
A presentation by Mike Graffeo, CEO, FluidForm.
The fields of tissue engineering and bioprinting have been hamstrung by challenges using the right materials assembled the way biology intended to recreate structure and function. In this presentation, you’ll learn about some of the work that has been done using the FRESH method to advance the field of tissue engineering.Continue reading “Advancing Bioprinting using FRESH printing”
Speakers from Nanyang Technological University Singapore, KU Leuven, Ghent University, RegenHu, FluidForm, ThinkMade, MERLN Maastricht University and 3DTech will be there to talk about the latest developments in 3D Bioprinting. See the complete program here.Continue reading “Only 1 week to register for Online 3D Bioprinting Conference. Don’t miss it, register now!”
presentation by Mauro Petretta, Senior Scientific Advisor, REGENHU
In this talk, I will give a brief overview of REGENHU, 3D bioprinting applications, from drug discovery to tablet formulation, and examples of how our partners have advanced their research using our instruments.Continue reading “3D Bioprinting: Shifting paradigms of healthcare”
presentation by Sanna Turunen, Product Manager, D.Sc. (Tech.), 3DTech Ltd. / Brinter Ltd.
Chondral lesions constitute one of the major extrinsic risk factors for Osteoarthritis (OA), leading to significant societal and economic burden. OA is a highly prevalent condition that can result in disabling pain and loss of physical function.Continue reading “The Restore project, User-centred smart nanobiomaterial-based 3D matrices for chondral repair”
a presentation by Wai Yee Yeong, Nanyang Technological University Singapore. 3D bioprinting is fast becoming an advanced manufacturing enabler for the future of healthcare and biotechnologies research. The bioprinting landscape is experiencing expansion and consolidation in terms of technologies strategies.Continue reading “3D Bioprinting: Strategies and Applications”
presentation by Dr. Ruth Houbertz, ThinkMade Engineering & Consulting
Optical technologies cover a broad range of applications which make use of the generation and the manipulation of light, and they open a wide field of novel applications when combined with (bio-) medicine. Many efforts have been made to develop laser light sources in order to continuously increase their application potential.Continue reading “3D-Printed Scaffolds for Tissue Engineering – Materials and Applications”
presentation by Reinhilde Jacobs, Professor Dentomaxillofacial Radiology & research coordinator OmfsImpath, University of Leuven
Missing teeth are nowadays often replaced by osseointegrated implants. Unfortunately, children with missing teeth can not be helped by such implant treatment. In the search for a solution to help such children, the idea of tooth bioprinting was introduced. When such concept could be developed, it might offer possibilities not only to help young patients with missing teeth, yet also it might be opened up to help all patients with missing teeth. The presentation will cover all challenges and opportunities to advance realizing this goal.Continue reading “On tooth bioprinting”
by Gabriele Addario, MERLN Institute
It is estimated that 10% of the worldwide population suffers from chronic kidney disease (CKD) with a rising tendency. Patients with CKD have limited treatment options and novel therapies that could halt or even reverse the progression of CKD are urgently needed. Bioprinting is considered one of the most promising approaches to generate novel 3D in vitro models and organ-like constructs to investigate underlying pathomechanisms of kidney diseases.Continue reading “Kidney tubulointerstitium: a microfluidic bioprinting approach”